Evidence map›Paper›PMID 15237056›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2004

The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.

V Anna Gyarmathy, József Rácz, Alan Neaigus, Eszter Ujhelyi

Open access · greenAbstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection.Journal of urban health : bulletin of the New York Academy of Medicine · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

V Anna GyarmathyThe National Development and Research Institutes, Inc., New York, NY 10010, USA. gyarmathy@ndri.org
József Rácz
Alan Neaigus
Eszter Ujhelyi
Columbia University · USHungarian Academy of Sciences · HUNational Development and Research Institutes · USUnified Szent István and Szent László Hospital · HU

Funding

Young Drug Users and HIV Risk in Budapest, HungaryR03DA015313 · NIDA · NATIONAL DEVELOPMENT &RES INSTITUTES · PI GYARMATHY, V ANNA · 2002 to 2003
$142k
NIDA NIH HHS R03 DA015313NIDA NIH HHS R03 DA15313-01
6 · The paper itself

Abstract

We assess HIV and hepatitis testing and counseling in drug treatment programs in Hungary, a country with low rates of HIV but high rates of hepatitis C among injection drug users. The official context of drug treatment programs is described, and using key informants from representative drug treatment programs, the practice of HIV and hepatitis testing and counseling in such programs is assessed. Although HIV testing and counseling occurs, testing and counseling for hepatitis B and C are rare, especially in outpatient settings, and sexual risk in the drug use context is ineffectively addressed by treatment programs. Drug treatment centers are not adequately addressing the need to provide either HIV or hepatitis prevention services. There is an urgent need for preventing HIV and related infections among drug users by integrating HIV and hepatitis B and C prevention with drug treatment.

Indexed as

CounselingHealth Services ResearchHepatitis BHepatitis CHIV InfectionsHumansHungaryPreventive Health ServicesSubstance Abuse Treatment CentersSubstance-Related Disorders

Identifiers

PMID15237056
PMCPMC2562463
OpenAlexW2091492605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.